Evidence map›Paper›PMID 17449461›Full record

ReviewNeurotoxicity research2007

Model fusion, the next phase in developing animal models for Parkinson's disease.

Amy B Manning-Bog, J William Langston

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neurotoxicity research, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Genetic and Environmental Factors Influence the Pleomorphy ofInternational journal of molecular sciences · 2021
    Review
  7. Autonomic dysfunction in Parkinson disease and animal models.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2019
    Review
  8. Review
  9. Article
  10. Article
  11. The MPTP Story.Journal of Parkinson's disease · 2017
    Review
  12. Article
  13. Article
  14. Heat shock proteins in neurodegenerative disorders and aging.Journal of cell communication and signaling · 2014
    Article
  15. Article
  16. Adaptation and sensitization to proteotoxic stress.Dose-response : a publication of International Hormesis Society · 2014
    Article
  17. Review
  18. Natural toxins implicated in the development of Parkinson's disease.Therapeutic advances in neurological disorders · 2011
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Amy B Manning-BogThe Parkinson's Institute, 1170 Morse Ave., Sunnyvale, CA 94089, USA.
J William Langston

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Within the past 25 years, discoveries of environmental and monogenetic forms of parkinsonism have shaped the direction of Parkinson's disease (PD) research and development of experimental systems to study PD. In this review, we outline a remarkable array of in vivo models available, with particular emphasis on their benefits and pitfalls and the contribution each has made to enhance our understanding of pathological mechanisms involved in PD. Further, we discuss the increasingly popular approach of "model fusion" to create a new generation of animal systems in which to study gene-environment interactions, and the usefulness of such models in capturing the most common events underlying PD.

Indexed as

Disease Models, AnimalParkinson DiseaseAnimalsAnimals, Genetically ModifiedEnvironmentGenesHumansNeurotoxinsNeurotoxins

Identifiers

PMID17449461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.